| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.55B | 35.64B | 31.05B | 25.15B | 21.02B | 21.53B |
| Gross Profit | 32.55B | 35.64B | 31.05B | 25.15B | 14.49B | 17.27B |
| EBITDA | 9.64B | 12.48B | 10.14B | 8.88B | 5.90B | -2.92B |
| Net Income | 6.28B | 8.04B | 5.99B | 5.73B | 3.56B | -3.32B |
Balance Sheet | ||||||
| Total Assets | 120.35B | 121.83B | 116.18B | 112.42B | 68.60B | 67.82B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 13.60B | 17.23B | 24.42B | 5.72B | 3.76B |
| Total Debt | 1.23B | 1.01B | 1.29B | 219.00M | 115.00M | 7.00M |
| Total Liabilities | 25.03B | 26.23B | 24.06B | 21.54B | 53.03B | 45.75B |
| Stockholders Equity | 95.31B | 95.60B | 92.11B | 90.87B | 75.69B | 22.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.99B | 6.10B | 5.23B | 2.12B | 2.27B |
| Operating Cash Flow | 0.00 | 8.82B | 7.28B | 6.02B | 2.68B | 2.78B |
| Investing Cash Flow | 0.00 | -12.18B | -14.29B | -3.44B | 763.00M | -7.75B |
| Financing Cash Flow | 0.00 | -282.00M | -164.00M | 9.68B | -109.00M | 9.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥5.98T | 13.49 | 10.61% | 3.26% | 10.30% | 3.49% | |
71 Outperform | ¥137.46B | 17.07 | ― | ― | 14.78% | 34.13% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥1.97T | 14.55 | 7.91% | 2.74% | -6.35% | 16.15% | |
63 Neutral | ¥35.53B | 8.51 | 4.94% | 4.00% | 8.60% | 46.50% | |
46 Neutral | ¥1.56T | 9.18 | ― | 2.44% | -12.57% | 42.29% | |
41 Neutral | ¥3.73B | -67.07 | 4.15% | ― | -31.54% | -110.01% |